BioMarin Pharmaceuticals

BMRN

Market cap $10.7B

Upgrade to unlock

Buy

Hold

Sell

8 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$81

45% upside

High target

8 analyst ratings

positive

2 neutral

25%

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
Stifel Paul Matteis 100% 1-yr BMRN win rate				6 Nov ‘25 24 days ago
Bernstein William Pickering 100% 1-yr BMRN win rate				3 Nov ‘25 27 days ago
Truist Securities Joon Lee 100% 1-yr BMRN win rate				28 Oct ‘25 1 month ago
Wells Fargo Mohit Bansal 100% 1-yr BMRN win rate				28 Oct ‘25 1 month ago
Barclays Gena Wang 100% 1-yr BMRN win rate				28 Oct ‘25 1 month ago
Morgan Stanley Matthew Harrison 50% 1-yr BMRN win rate				28 Oct ‘25 1 month ago
HC Wainwright & Co Mitchell Kapoor				27 Oct ‘25 1 month ago
JP Morgan Jessica Fye 50% 1-yr BMRN win rate				9 Oct ‘25 1 month ago